跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
IRINOTECAN HYDROCHLORIDE INJECTION, USP
Authorized
STANDARD
IRINOTECAN HYDROCHLORIDE INJECTION, USP
generic medical partners inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9fe7f4c128391890
Company
generic medical partners inc
Type
Standard
Approval Details
Approval Id
9fe7f4c128391890
Drug Approval Canada Name
IRINOTECAN HYDROCHLORIDE INJECTION, USP
Product Name
IRINOTECAN HYDROCHLORIDE INJECTION, USP
Status
Marketed
Status Date
2024-05-22
Original Market Date
2024-05-22
Din
02452421
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01CE02 IRINOTECAN
Atc Name
l 01 ce 02
Aig Number
0132910001
Company Name
generic medical partners inc
Company Address
1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4
Active Ingredients
IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9fe7f4c128391890
Type
Standard
Back to Health Canada Approvals
IRINOTECAN HYDROCHLORIDE INJECTION, USP - Health Canada Drug Approval Details